Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests more cancer patients receiving aggressive care at end of life

14.01.2004


A growing number of cancer patients are receiving aggressive treatments when they are near death, according to a study led by researchers at Dana-Farber Cancer Institute. The findings will be published in the Jan. 15 issue of the Journal of Clinical Oncology.



"Our research has shown that the treatment of cancer patients near death is becoming increasingly aggressive and that more patients are being admitted to emergency rooms and to intensive care units during their last few weeks of life," says the study’s first author, Craig Earle, MD, of Dana-Farber. Earle presented preliminary data from the study at the annual meeting of the American Society of Clinical Oncology in Chicago in June 2003.

The researchers reviewed the records of 28,777 Medicare-eligible patients aged 65 and older who died within one year of being diagnosed with lung, breast, colorectal, and other gastrointestinal tumors between 1993 and 1996. They found that during this four-year period, the use of chemotherapy among these patients increased from 27.9 percent to 29.5 percent. Among those, the proportion receiving chemotherapy within two weeks of dying grew from 13.8 percent to 18.5 percent.


The researchers also observed an increase in the number of these patients who, during their last month of life, were seen in the emergency room (7.2 percent in 1993 to 9.2 percent in 1996) or admitted to an intensive care unit (7.1 percent to 9.4 percent). However, they also found that fewer patients were dying in acute-care hospitals (29.5 percent, down from 32.9 percent) and more were using hospice care (38.8 percent, up from 29.3 percent).

"Interestingly, the findings suggest that the availability of hospice services and related medical resources may reduce the chance that a patient will receive aggressive treatment at the end-of life," said Earle, who also is an assistant professor of medicine at Harvard Medical School. "Increasing the availability of hospice may improve the quality of care for many terminally ill patients."


The study’s other authors are Bridget A. Neville, MPH, Susan D. Block, MD, and Jane C. Weeks, MD, Dana-Farber, Mary Beth Landrum, PhD, Harvard Medical School, and John Z. Ayanian, MD, MPP, Harvard Medical School and Brigham and Women’s Hospital.

The research was funded in part by the National Cancer Institute.

Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a designated comprehensive cancer center by the National Cancer Institute.

Bill Schaller | EurekAlert!
Further information:
http://www.dana-farber.org

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>